Canada Inhalable Drugs Market Size & Outlook, 2025-2030

The inhalable drugs market in Canada is expected to reach a projected revenue of US$ 1,232.0 million by 2030. A compound annual growth rate of 6.3% is expected of Canada inhalable drugs market from 2025 to 2030.
Revenue, 2024 (US$M)
$849.1
Forecast, 2030 (US$M)
$1,232.0
CAGR, 2025 - 2030
6.3%
Report Coverage
Canada

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Canada inhalable drugs market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Canada inhalable drugs market highlights

  • The Canada inhalable drugs market generated a revenue of USD 849.1 million in 2024 and is expected to reach USD 1,232.0 million by 2030.
  • The Canada market is expected to grow at a CAGR of 6.3% from 2025 to 2030.
  • In terms of segment, dry powder formulation was the largest revenue generating product in 2024.
  • Dry powder formulation is the most lucrative product segment registering the fastest growth during the forecast period.

Inhalable drugs market data book summary

Market revenue in 2024USD 849.1 million
Market revenue in 2030USD 1,232.0 million
Growth rate6.3% (CAGR from 2025 to 2030)
Largest segmentDry powder formulation
Fastest growing segmentDry powder formulation
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationAerosol, Dry powder formulation, Spray
Key market players worldwideAstraZeneca PLC, Sanofi SA, Philip Morris International Inc, Viatris Inc, GSK PLC, Boehringer Ingelheim, Cipla Ltd DR, Boehringer Ingelheim Pharma

Other key industry trends

  • In terms of revenue, Canada accounted for 3.7% of the global inhalable drugs market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. inhalable drugs market is projected to lead the regional market in terms of revenue in 2030.
  • Mexico is the fastest growing regional market in North America and is projected to reach USD 118.4 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Inhalable Drugs Market Companies

Name Profile # Employees HQ Website
Boehringer Ingelheim Pharma View profile 10001+ Dortmund, Nordrhein-Westfalen, Germany, Europe https://www.boehringer-ingelheim.de/unternehmensprofil/unser-unternehmen/standort-dortmund
Philip Morris International Inc View profile 82700 677 Washington Boulevard, Suite 1100, Stamford, New York, NY, United States, 06901 https://www.pmi.com
Viatris Inc View profile 38000 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317 https://www.viatris.com
AstraZeneca PLC View profile 89900 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA https://www.astrazeneca.com
Boehringer Ingelheim View profile 10001+ Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe https://www.boehringer-ingelheim.com/
GSK PLC View profile 70200 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS https://www.gsk.com
Cipla Ltd DR View profile 38955 Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, India, 400 013 https://www.cipla.com
Sanofi SA View profile 87994 46, avenue de la Grande Armée, Paris, France, 75017 https://www.sanofi.com

Canada inhalable drugs market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to inhalable drugs market will help companies and investors design strategic landscapes.


Dry powder formulation was the largest segment with a revenue share of 44.56% in 2024. Horizon Databook has segmented the Canada inhalable drugs market based on aerosol, dry powder formulation, spray covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Canada inhalable drugs market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Canada inhalable drugs market databook

  • Our clientele includes a mix of inhalable drugs market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Canada inhalable drugs market , including forecasts for subscribers. This country databook contains high-level insights into Canada inhalable drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Canada inhalable drugs market size, by product, 2018-2030 (US$M)

Canada Inhalable Drugs Market Outlook Share, 2024 & 2030 (US$M)

Canada inhalable drugs market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online